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INTRODUCTION
Lectins of plant origin are very common in both human 
and animal diets, with evidence of their interaction with 
the gut [2, 19]. For instance, oral administration of red kid-
ney bean (Phaseolus vulgaris) lectin, phytohaemagglutinin 
(PHA), over a 3 d period in young suckling rats resulted 
in gut maturation in terms of epithelial development and 
decreased lactase as well as increased maltase and sucrase 
activities [15]. Moreover, the authors reported a reduction 
in macromolecular absorptive capacity, sometimes referred 
to as gut closure [15]. Of importance here is the fact that 
these changes usually occur in rats weaned under normal 
physiological conditions [26]. PHA also affects the pan-
creas of rats, leading to an increase in its weight relative 
to that of body weight (BW) as well as enhancing its exo-
crine function [15]. It seems logical to accept, therefore, 
that dietary lectins (including PHA) accelerate the turno-
ver of gastro-intestinal tract (GI-tract) cells. This being the 
case, rapid cell proliferation might be expected to result in 
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both increased gut growth and functional maturation, and 
as a further consequence, an increase in the use of dietary 
amino acids for protein synthesis by enterocytes [14, 16].
Glutamine, and one of its derivatives, namely alpha-ke-
toglutaric acid (AKG), are considered crucial molecules in 
trans-membrane amino acid transport, protein metabolism, 
and both gene and cellular redox regulation [30]. Animal, 
and indeed human studies alike, have shown that 95% of 
luminal glutamate and 70% of glutamine, but only 40% 
of AKG, is metabolized (fi rst pass) to CO2 by the intesti-
nal mucosa [11, 13]. Deamination of amino acids releas-
ing amino nitrogen for growth results in the production of 
ammonia, which is generally protonated to ammonium at 
physiological pH. There is, however, some evidence that 
the ammonia ion itself may be an essential part of the ap-
propriate environment for growth of enterocytes [32]. In-
deed, ammonia, which is toxic and therefore maintained at 
a very low level in the blood, has been shown to be convert-
ed from extracellular or intra-mitochondrially generated 
ammonia to urea by enterocytes in post-weaned pigs [30]. 
Alternatively, AKG, which serves as a natural scavenger of 
ammonium, facilitates its conversion to amino acids and 
protein [21, 25, 31], and by reducing levels of ammonium 
in the body it has a benefi cial effect on nitrogen metabo-
lism. Indeed, in this way, one might also regard AKG as 
having a role as a protective agent for kidney function [29], 
with a knock-on benefi t for osteoporosis, which is one of 
the most common bone disorder linked with nutritional and 
environmental factors [6, 7, 8].
Whilst the effects of PHA on intestinal cell turnover and 
those of AKG on nitrogen metabolism have been studied 
independently, their combined effect remains unknown. 
One might, however, suppose that an accelerated cellu-
lar turnover in enterocytes upon addition of PHA, result-
ing in an increase in ammonia production, in the presence 
of AKG, will rather promote its incorporation into amino 
acids and reduce the levels of urea produced, thereby al-
leviating renal function while at the same time enhancing 
amino nitrogen levels for growth.
The aim of the present study was therefore to investi-
gate the effect of oral supplementation of PHA alone and 
in combination with AKG on GI-tract morphology and the 
growth and nitrogen balance in rats.
METHODS AND MATERIALS
Rats came from the Sprague Dawley outbred Labora-
tory (M&B A/S, Denmark), and were caged individually 
in metabolic cages (60% humidity with 12 h of light per 
24 h) at the Dept. of Animal Physiology, Lund, Sweden. 
Rats were given ad libitum access to food: a wheat, barley, 
extracted soya bean meal, fat blend, mineral, vitamin and 
amino acid mix with a dietary composition (%) Dig. Crude 
Protein 17.37, Dig. Crude Opil 3.76, Calcium 0.65, total 
Phosphorus 0.51 of which 0.24 was available, Lysine 1.26 
and Methionine 0.30, and a Dig. Energy of 13.75 MJ/kg.
The vitamin content per kg of diet comprised: Vitamin 
A, 14960 I.U.; Vitamin D3, 1574 I.U.; Vitamin E, 110.4 
mg; Thiamin, 17.6 mg; Ribofl avin, 13.2 mg; Pyrodoxine, 
17.9 mg; Vitamin B12, 35 μg; Vitamin K, 19.9 mg; Folic 
Acid, 3.1 mg; Nicotinic Acid; 34.1 mg; Panthotenic Acid, 
34.1 mg; Choline, 1557.0 mg; Inositol, 1811.4 mg; Biotin, 
369.2 μg (Tab. 1). The study was approved by the Ethi-
cal Review Committee for Animal Experiments at Lund 
University, and conducted according to European Commu-
nity regulations concerning the protection of experimental 
animals.
Groups were equalised with regard to body weight. Food 
and water consumption as well as urine and faeces produc-
tion were measured daily. Treatments and experimental 
conditions were conducted according to the recommenda-
tions of the Federation of the European Laboratory Animal 
Science Association (FELASA).
Experiment 1. Rats were assigned to 2 experimental 
groups and kept in metabolic cages: 1) Control, 2) PHA, 
with 6 animals in the Control group, and 6 in the treat-
ment group. Stomach tube was applied once each day in 
the morning in all animals, while PHA was administered 
via a stomach tube in PHA group. The stock solution of 
crude PHA in 0.9% NaCl was (20% w/v) in water: 50 mg 
PHA/ml, 20 ml/kg body weight. Control rats were admin-
istered HCl (1 M) orally at a rate of 2.1 ml/l in the drinking 
water to compensate for the acidic effect of the PHA prepa-
ration (pH 6.0). Male rats were 17 weeks old at the start of 
the trial and remained part of the study for 11 days. Their 
initial body weight was 236.0 ± 1.4 g.
Experiment 2. Male rats were divided into 3 experi-
mental groups and kept in metabolic cages: 1) Control, 2) 
AKG, 3) AKG+PHA, with 5 animals in the Control group 
and 6 in the treatment groups. Stomach tube was applied 
Table 1. Composition of diet fed to rats for 11 days (Experiment 1) and 
9 days (Experiment 2). Main ingredients: wheat, barley, extracted soya 
bean meal, fat blend, minerals, vitamin premixa, amino acids.
Calculated dietary composition %
Dig. Crude Protein 17.37
Dig. Crude Oil 3.76
Dig. energy, MJ/kg 13.75
Calcium 0.65
Total Phosphorus 0.51
Available Phosphorus 0.24
Lysine 1.26
Methionine 0.30
aProviding the following per kilogram of diet (g/kg diet): Vitamin A, 14960 
I.U; Vitamin D3, 1574 I.U; Vitamin E, 110.4 mg; Thiamin, 17.6 mg; Ribo-
fl avin, 13.2 mg; Pyrodoxine, 17.9 mg; Vitamin B12, 35 μg; Vitamin K, 19.9 
mg; Folic Acid, 3.1 mg; Nicotinic Acid; 34.1 mg; Panthotenic Acid, 34.1 
mg; Choline, 1557.0 mg; Inositol, 1811.4 mg; Biotin, 369.2 μg.
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once each day in the morning in all animals, while PHA 
was administered via a stomach tube in PHA group. AKG 
was administered via the drinking water. The stock solution 
of crude PHA in 0.9% NaCl was administered (20% w/v) 
in water: 50 mg PHA/ml, 20 ml/kg body weight. Control 
rats were administered HCl (1 M) orally at a rate of 10.5 
ml/l in the drinking water to compensate for the acidic ef-
fect of the AKG preparation (pH 2.0). Rats were 17 weeks 
old at the start of the trial and remained part of the study for 
9 days. Their initial body weight was 252.6 ± 1.0 g.
Urine and faeces sampling. Collection of urine into a 
cup was performed every day, with 10 ml of a 50% H2SO4 
solution being used to stop microbial activity, while faeces, 
which was also collected in a cup, was kept dry. The total 
volume of urine was measured, and a homogenised sample 
of 10 ml was collected for urea analysis. The weight of the 
faeces was also measured on a daily basis, followed by col-
lecting into 60 ml of a 50% H2SO4 solution. At the end of 
the experiment the total collection of faeces was analysed 
for nitrogen content.
Analysis of total Nitrogen. Nitrogen content was meas-
ured on a Leco Nitrogen and Protein Determinator FP-428 
(Leco Corporation. St. Joseph. MI., USA). The instrument 
was set up in low range mode. Prior to analysis, the fae-
cal samples were homogenised (Sorvall Omni-Mixer). The 
faecal samples, 150–200 mg, were analysed in tin foil cups. 
The urine samples (100–200 μl) were analysed in tin cap-
sules measuring 15 × 6 mm (length/diameter). To obtain 
urine samples for nitrogen determination, aliquots of 1% of 
the daily urine volume were pooled. A glycine standard so-
lution containing 1% nitrogen was used as a reference. All 
nitrogen determinations were made on duplicate samples.
Collection of GI-tract content and samples for his-
topathological analysis. At the end of the trial, rats were 
euthanized with an overdose of pentobarbital; stomach con-
tents, proximal and distal small intestine, caecum and colon 
were collected, weighed and prepared for measurement of 
AKG concentration. Duodenum was fi xed in Bouin’s solu-
tion, and then dehydrated and embedded in paraffi n. Paraffi n 
sections (5 μm) were cut and mounted on Super Frost/Plus 
slides (Histolab, Sweden). For histological study using a 
light microscope, a hematoxylin and eosin stain was used. 
Duodenal preparations were measured for crypt depth, tuni-
ca mucosa thickness, epithelial cell height and basal width. 
From each animal, 40 well-oriented villi and crypts not tak-
en from an area with Peyer’s patches, were measured at low 
magnifi cation (objective × 2.5). Tunica mucosa thickness 
was measured as the distance from the muscularis mucosa 
to the tip of villus, whereas crypt depth was measured from 
the muscularis mucosa to the level of the crypt opening. The 
enterocyte height of 10 well-oriented villi was measured us-
ing high magnifi cation (objective × 100). One thousand cells 
were examined from each animal.
Immunohistochemistry. Immunohistochemical reac-
tions were performed with monoclonal antisera against 
neuropeptide Y (Sigma, Sweden) or cholecystokinin 
(CCK) (Sigma, Sweden) using a dilution of 1/8,000. An in-
direct avidin-biotin-peroxidase method was applied, using 
Histomouse SP Bulk kit Broad Spectrum (Zymed, USA). 
Peroxidase was visualised using 3-amino, 9-ethylcarba-
zole as a chromogen, and the sections were lightly counter-
stained with hematoxylin according to the manufacturer’s 
instructions. Sections were stained at the same time. The 
specifi city of the stain was controlled by substitution of the 
primary antibody for buffer.
Calculations and statistics. Total feed intake was 
calculated from the level of food used per day, although 
an approximation was made to compensate for any feed 
which entered the cup used for collecting feces. This cor-
rection factor was found to be constant for all treatments 
and amounted to 10.77% of the total feed provided. The 
fi nal feed intake was therefore adjusted using this factor. 
The nitrogen level of the feed was calculated from the level 
of protein in the feed – 19.76%. Data, which were normally 
distributed and of equal variance, were analysed for statis-
tical signifi cance between means using the student’s t-test. 
A comparison of each variable in the histopathological 
analysis was performed using a one-way ANOVA. If the 
overall ANOVA proved to be signifi cant, pair-wise com-
parisons using a t-test were then performed. In all statisti-
cal analyses p<0.05 was considered signifi cant.
RESULTS
Performance. Experiment 1: the average starting 
weight of the Control group, was 237.6 g, and the body 
weight of the treated groups was not signifi cantly different 
from that of the Controls. The results showed signifi cantly 
lower daily weight gain as well as fi nal body weight (data 
not shown) for the PHA group, compared to the Controls 
(p<0.05) (Tab. 2). Compared to the Control group, feed in-
take was signifi cantly reduced in the PHA group (approx. 
10% reduction; p<0.05) (Tab. 2).
Experiment 2: the average starting weight of the Con-
trol group was 252.6 g, and the body weight of the treated 
groups was not signifi cantly different from that of the Con-
trols. The results showed a signifi cantly lower daily weight 
gain in the AKG+PHA group (p<0.05), compared to that of 
the Control and AKG groups (Tab. 2). The fi nal body weight 
was also found to be lighter compared to both the Control 
and AKG groups (p<0.05, data not shown). Total water in-
take appeared reduced in the treatment groups compared to 
the Controls; this difference, however, was only signifi cant 
for the AKG+PHA group (47% lower; p<0.05).
Urinary and faecal N. In experiment 1, a signifi cant 
reduction in urine production was found between the Con-
trols and the PHA treated rats, although no difference in the 
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total level of excreted faeces was found between the two 
groups (Tab. 2).
In Experiment 2, there was a signifi cant reduction in the lev-
el of urine excreted in both the AKG and AKG+PHA groups 
compared with the Controls (p<0.05), with the combined ef-
fect of AKG+PHA yielding a greater reduction than that of 
AKG alone – 66% and 50%, respectively. There was no dif-
ference between treatments with respect to the fi nal amount of 
faeces excreted after 9 days of trial (p<0.05) (Tab. 2).
In Experiment 1, a signifi cant reduction in N excretion 
in urine was observed in the PHA group, compared to the 
Control group (16% lower; p<0.05) (Tab. 3). Similarly, in 
Experiment 2, a reduction in N excretion in urine was ob-
served in the AKG+PHA group, compared to the Control 
and AKG groups (34% lower; p<0.05). However, in the 
AKG group numeric reduction (trend) of N excretion was 
observed, compared to Control.
Calculation of the relative level of N in faeces to the total 
N intake (Faecal N/intake N%) showed that in AKG+PHA 
treated animals the percentage of N excreted in faeces in-
creased, compared to the Control group, in favour of N ex-
cretion via the faeces. This was also visible after calculat-
ing the percentage of N excreted in faeces in relation to the 
N excreted in both faeces and urine (Faecal N/(urine N + 
faecal N) %) (Tab. 3).
Similarly, after hypothetical estimation of ingested pro-
tein, in AKG+PHA and in AKG treated animals the per-
centage of proteins excreted in faeces and urine differed 
compared to the Control group in favour of excretion via 
the feces (Tab. 3).
Gastro-intestinal tract weights. Experiment 1: In the 
PHA group, an increased total GI-tract weight was observed, 
compared to that of the Control group (p<0.05) (Tab. 4).
Experiment 2: In general, the changes infl uenced by 
the different treatments were related to the small intestine 
and large intestine. In the AKG+PHA group an increased 
weight of both small intestine and large intestine was noted 
(p<0.05) (Tab. 4).
Gastro-intestinal tract morphology. Experiment 2: 
The morphometric analysis of the duodenum taken from 
animals treated with PHA+AKG showed a signifi cant dif-
ference (p<0.05), compared to that of the Control group 
with regard to crypt depth (138% increase compared with 
the 173.9 ± 18.7 μm crypt depth of the Controls. No sig-
nifi cant difference in the thickness of tunica mucosa was 
found between the Control and treatment groups. Moreo-
ver, morphometric analysis of the intestinal cells – height 
and basal width of enterocytes – showed no difference 
Table 2. Mean daily growth performance, feed and water intake, excretion of urine and feces in rats.
Measurements Experiment 1 Experiment 2 AKG+PHA
Control PHA Control AKG
Daily gain (g) 4.8 ± 0.3 2.9 ± 0.9* 5.4 ± 0.4 6.0 ± 0.4 3.2 ± 0.3*
Feed intake (g)a 22.9 ± 1.9 20.5 ± 1.6* 22.4 ± 1.2 23.6 ± 0.8 19.8 ± 1.0
Water intake (mL) 53.3 ± 9.5 21.2 ± 2.6* 48.0± 6.0 33.4 ± 2.2 25.4 ± 3.4**
Urine (Ml) 33.1 ± 7.1 8.9 ± 1.5* 31.9 ± 6.2 16.1 ± 1.7* 10.7 ± 1.7*
Feces (g) 11.2 ± 0.6 11.9 ± 0.5 11.7 ± 2.1 11.6 ± 1.5 11.4 ± 2.9
Values are means ± SEM. Signifi cance of changes against Control in each experiment (Student’s t-test): *p <0.05, **p < 0.01. aCorrection was made to 
compensate for any feed which entered the cup used for collecting feces (≈10.77% of total feed provided).
Table 3. Mean daily intake and excretion of nitrogen (N) in rats.
Measurements Experiment 1 Experiment 2 AKG+PHA
Control PHA Control AKG
Intake of N in feed (g/d)a 0.65 ± 0.02 0.58 ± 0.04 0.68 ± 0.03 0.72 ± 0.02 0.61 ± 0.03
N in Urine (g/d) 0.36 ± 0.02 0.30 ± 0.02* 0.38 ± 0.02 0.33 ± 0.02 0.25 ± 0.01**
N in Feces (g/d) 0.13 ± 0.003 0.14 ± 0.01 0.14 ± 0.007 0.15 ± 0.01 0.15 ± 0.01
N for Growth (g)b 0.12 ± 0.01 0.07 ± 0.02 0.14 ± 0.01 0.15 ± 0.01 0.08 ± 0.006
N balance (g) 0.16 0.14 0.16 0.24 0.21
Urine N/ intake N (%) 55.4 51.7 55.9 45.8 40.9
Fecal N/ intake N % 20.0 24.1 20.6 20.8 24.6
Fecal N/ (urine N + fecal N) (%) 26.5 31.8 26.9 31.2 37.5
Relative consumed protein in urine vs feces (%)c 56.6 : 25.1 52.5 : 24.4 60.9 : 22.3 50.3 : 22.7 45.5 : 27.1
Values are means ± SEM. Signifi cance of changes against Control in each experiment (Student’s t-test): *p<0.05, **p<0.001. aCalculated level of con-
sumed N = (Total feed consumption × protein level in feed (0.1967) × true protein dig. (0.868))/6.25. bCalculated level of N used for growth = (Total 
growth, g) × level of protein in fl esh (0.16))/6.25. cProtein content was estimated by multiplying total N × 6.25 (based on FAO/WHO, 1973).
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between the Control group and the AKG+PHA treated rats. 
(data not shown).
The results of immunohistochemical examination of the 
duodenum showed no difference in abundance of CCK 
positive cells in the tunica mucosa between Controls and 
the AKG+PHA group. However, a difference in neuropep-
tide Y (NPY) positive material was noticeable. In the Con-
trol group, the expression of NPY was present in both gran-
ules of neuronal cells of the submucosal parasympathetic 
ganglia and goblet cells of the epithelium. In contrast, in 
the AKG+PHA group, only expression of NPY in granules 
of neuronal cells of the submucosal parasympathetic gan-
glia, without any expression in goblet cells, was noticeable 
(data not shown).
DISCUSSION
Effect of PHA and AKG on urinary and faecal N bal-
ance. Daily urine excretion depends on a number of differ-
ent factors, among which water intake is one of the most 
important, yet under physiological conditions it has no in-
fl uence on total urea (and nitrogen) excretion via the kid-
neys [22]. The present study shows that AKG+PHA treat-
ment alters the proportion of N excreted in urine cf that of 
faeces, so that faecal N excretion appears to be favoured. 
Moreover, it is important to note that the addition of AKG 
alone to the diet did not exert any infl uence on the amount 
of N excreted in the urine or faeces. The reduction of the 
urine excretion in PHA treated rats was not followed by the 
reduction of N excretion via urine and therefore, it may be 
attributed to the reduced water intake.
Rat performance. In the present study, PHA treatment 
in rats negatively infl uenced both performance and food 
intake, which supports previous fi ndings showing that the 
ingestion of PHA (from red kidney beans) leads to a reduc-
tion in body weight, and at high doses may damage the 
gut mucosa. However, lectin at low doses (0.01–0.2 g/kg 
BW) does not exert a strong anti-nutritional effect in rats 
and, in general, may cause a reversible dose-dependent hy-
perplastic growth of the intestinal wall [2]. Moreover, re-
sults from a recent piglet study showed an improvement in 
performance with PHA treatment [27]. This positive effect 
on performance was attributed to a lower total diarrhoeal 
score, which in itself can arise through an increased matu-
ration of the gastro-intestinal (GI) tract post-weaning, with 
PHA treatment [20]. In the present study we found that 
PHA treatment had no adverse effect on GI-tract weights in 
terms of stomach, small and large intestine and caecum. In 
fact, there was a trend towards an increase in total GI-tract 
weight (113% with PHA cf Controls), although this was 
not signifi cant. Similarly, AKG treatment had no adverse 
effect on GI-tract weights. Interestingly, the addition of 
AKG+PHA to the diet signifi cantly increased small intesti-
nal weight by 117% and large intestine weight by 125% cf 
Controls. The results of the present study pertaining to the 
weight of the GI-tract generally substantiate previous fi nd-
ings [1, 2, 16, 18, 22] in that the weight of the small intes-
tine was signifi cantly increased with PHA treatment. This 
was also confi rmed by calculation of the ratio of total body 
weight/GI-tract weight, where in the PHA treatment group 
the ratio was 4.5 (AKG+PHA), while in the Control and 
AKG treatment groups the ratio was 3.6 (data not shown).
Effect of PHA and AKG on the morphology of the 
gut & CCK/NPY expression. Increased crypt depth in 
PHA treated animals supports the fi ndings of previous 
studies [2, 14, 16, 20] in that PHA treatment increases the 
weight of the small intestine by increasing cell production 
rate. The underlying mechanism for the PHA effect is most 
likely the same as for some peptide growth factors and hor-
mones – it binds to cell surface receptors of the brush bor-
der membrane, and acts as an extraneous growth factor in 
the gut. By interacting with brush border epithelial recep-
tors, PHA induces extensive proliferation and changes in 
the metabolism of epithelial cells by activation of second 
messenger pathways [2]. It has also been shown that plant 
lectins bind avidly to the mucosal surface and induce dose- 
and time-dependent as well as fully reversible hyperplastic 
and hypertrophic growth in the small intestine [2].
PHA is one of the most powerful growth factors in the rat 
alimentary tract [1, 3]. A 10-day oral PHA treatment induc-
es dose dependent growth in the small intestine and pan-
creas. However, the mechanism underlying this effect re-
mains unknown [18]. Gastro-intestinal peptides, especially 
cholecystokinin (CCK), have been shown to be involved in 
the regulation of pancreas growth and function [17]. It has 
also been shown that PHA signifi cantly stimulates small 
Table 4. Mean weights (g) of the selected rat GI-tract parts at the end of the experiments.
GI-tract Experiment 1 Experiment 2 AKG+PHA
Control PHA Control AKG
Stomach (g) 1.2 ± 0.03 1.2 ± 0.05 1.5 ± 0.07 1.4 ± 0.07 1.4 ± 0.04
Small Intestine (g) 6.6 ± 0.13 7.9 ± 0.52 6.9 ± 0.06 7.1 ± 0.33 8.1 ± 0.30**
Large Intestine (g) 1.1 ± 0.13 1.0 ± 0.02 1.2 ± 0.07 1.3 ± 0.08 1.5 ± 0.06*
Cecum (g) 1.1 ± 0.13 1.2 ± 0.08* 1.3 ± 0.1 1.2 ± 0.07 1.4 ± 0.08
Total GI-tract (g) 10.0 ± 0.11 11.3 ± 0.63* 10.9 ± 0.09 11.0 ± 0.38 12.4 ± 0.38*
Values are means ± SEM. Signifi cance of changes against Control in each experiment (Student’s t-test): *p<0.05, **p<0.01.
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intestinal growth by a CCK independent mechanism, and 
pancreatic hypertrophy by a CCK dependent mechanism 
[10, 24]. Moreover, PHA in vitro directly and dose depend-
ently releases CCK from isolated intestinal mucosa cells 
[5]. The exact mechanism of lectin-induced CCK release 
from CCK cells in the intestine has yet to be elucidated, 
but it is hypothesised that lectins infl uence CCK cell activ-
ity by binding to the glycosyl side chains of voltage-gated 
channels [23]. Among other peptides and hormones (e.g. 
gastrin, enteroglucagon, glucagon, and peptide YY) which 
have been profoundly investigated under PHA treatment, 
only insulin has been shown to have a trophic effect on the 
pancreas and the intestine of rats [1, 4]. NPY is a peptide 
that is known to stimulate feeding, and NPY – immuno-re-
active nerve cells are ubiquitous in the submucosal ganglia. 
Our results indicate that oral PHA+AKG treatment may 
lead to an alteration of NPY expression in the duodenum 
of rats. The physiological effect of this alteration may be an 
increase in duodenal intra-luminal pressure, together with 
involvement in the regulation of inter-digestive motility of 
the small intestine [9]. It may therefore be speculated that 
AKG+PHA, instead of infl uencing gut morphology, may 
rather exert an effect on the rapidity of feed passage through 
the GI-tract of an animal, the so-called transit time.
In conclusion, the present results indicate that PHA, 
administered alone or in the presence of AKG, stimulates 
small bowel growth in rats by increasing crypt depth and 
the weight of the small intestine. The consequence of such 
changes will most likely be: 1) a higher rate of protein 
production in the intestinal wall, and 2) a change in the 
proportion of N excretion via urine and faeces, apparently 
favouring faecal excretion. While it is proposed that further 
studies are needed in order to elucidate the action and role 
of AKG, this study reveals new perspectives for the treat-
ment of injured intestinal mucosa, as well as some poten-
tial in prolonging the inter-dialysis period in subjects with 
chronic renal failure.
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